Novartis CEO Backs Malaria Drug Against COVID-19
Also Testing Jakavi, Gilenya And Ilaris
A coronavirus vaccine is some way off and until then, Vas Narasimhan, head of Novartis, is thinking that of the drugs being repurposed to treat COVID-19, hydroxychloroquine looks best placed to provide the quickest benefit.
